Women aged 65 and above are still at heightened risk of cervical cancer caused by human papillomavirus (HPV), suggest the findings of a large observational study published in the open access journal ...

Yet, in Nigeria's campaign to increase the uptake of the Human Papillomavirus (HPV) vaccine, Internally Displaced Persons (IDPs) are often excluded. With over 1.3 million IDPs displaced by conflict ...

Geneva resident Keith Giffney beat stage 4 cancer of the tonsil, neck and chest to go on and complete a Half Ironman ...

SOLUTION Group Bhd (SGB), through its wholly-owned subsidiary Solution Biologics Sdn Bhd (SOLBIO), has signed an exclusive ...

Biological E Ltd. has partnered with Jiangsu Recbio Technology to commercialize the latter's HPV9 vaccine, REC603, in India.

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

The screening test checks for the presence of the human papillomavirus or HPV. Some types of HPV can cause changes in the ...

Low screening coverage, late diagnoses, high HIV prevalence, and limited access to treatment and vaccines are driving cervical cancer cases and deaths in South Africa. The country has a cervical ...

Jiangsu Recbio Technology and Biological E. Limited are partnering for HPV9 vaccine. Recbio will transfer technology to ...

HYDERABAD: Jiangsu Recbio Technology Co. Ltd, a leading Chinese biopharmaceutical firm, has entered into a licensing and ...

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...